Treatment-related adverse events, assessed according to common terminology criteria for adverse events version 5.0, were grade 1 leukopenia, anemia, increased alanine aminotransferase, increased aspartate aminotransferase, and grade 2 increased serum creatinine. This evidence concerns the gene GPT and Decreased total leukocyte count.